Dynamic Drusen Remodelling in Participants of the Nutritional AMD Treatment-2 (NAT-2) Randomized Trial.
PURPOSE:To evaluate the dynamic remodeling of drusen in subjects with unilateral neovascular age-related macular degeneration (AMD) receiving a three-year course of oral docosahexaenoic acid (DHA) or placebo. SETTING:Institutional setting. METHODS:Three hundred subjects with age-related maculopathy...
Main Authors: | Giuseppe Querques, Bénédicte M J Merle, Nicole M Pumariega, Pascale Benlian, Cécile Delcourt, Alain Zourdani, Heather B Leisy, Michele D Lee, R Theodore Smith, Eric H Souied |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4762680?pdf=render |
Similar Items
-
CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study.
by: Bénédicte M J Merle, et al.
Published: (2015-01-01) -
DHA supplementation for late onset Stargardt disease: NAT-3 study
by: Giuseppe Querques, et al.
Published: (2010-06-01) -
System analysis of factors in the pathogenesis of drusen formation in AMD
by: S.Yu. Mogilevskyy, et al.
Published: (2020-04-01) -
Using directional OCT to analyze photoreceptor visibility over AMD-related drusen
by: Brennan Marsh-Armstrong, et al.
Published: (2022-06-01) -
Characterization of drusen formation in a primary porcine tissue culture model of dry AMD
by: Erika M. Shaw, et al.
Published: (2024-12-01)